Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1993 Dec 4;307(6917):1435–1436. doi: 10.1136/bmj.307.6917.1435

Preventing insulin dependent diabetes mellitus.

K G Alberti
PMCID: PMC1679481  PMID: 8166808

Full text

PDF
1435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baekkeskov S., Aanstoot H. J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., De Camilli P., Camilli P. D. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990 Sep 13;347(6289):151–156. doi: 10.1038/347151a0. [DOI] [PubMed] [Google Scholar]
  2. Bougneres P. F., Carel J. C., Castano L., Boitard C., Gardin J. P., Landais P., Hors J., Mihatsch M. J., Paillard M., Chaussain J. L. Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med. 1988 Mar 17;318(11):663–670. doi: 10.1056/NEJM198803173181103. [DOI] [PubMed] [Google Scholar]
  3. Eizirik D. L., Sandler S., Palmer J. P. Repair of pancreatic beta-cells. A relevant phenomenon in early IDDM? Diabetes. 1993 Oct;42(10):1383–1391. doi: 10.2337/diab.42.10.1383. [DOI] [PubMed] [Google Scholar]
  4. Elliott R. B., Chase H. P. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia. 1991 May;34(5):362–365. doi: 10.1007/BF00405010. [DOI] [PubMed] [Google Scholar]
  5. Harrison L. C., Colman P. G., Dean B., Baxter R., Martin F. I. Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine. Diabetes. 1985 Dec;34(12):1306–1308. doi: 10.2337/diab.34.12.1306. [DOI] [PubMed] [Google Scholar]
  6. Keller R. J., Eisenbarth G. S., Jackson R. A. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet. 1993 Apr 10;341(8850):927–928. doi: 10.1016/0140-6736(93)91215-8. [DOI] [PubMed] [Google Scholar]
  7. Pietropaolo M., Castaño L., Babu S., Buelow R., Kuo Y. L., Martin S., Martin A., Powers A. C., Prochazka M., Naggert J. Islet cell autoantigen 69 kD (ICA69). Molecular cloning and characterization of a novel diabetes-associated autoantigen. J Clin Invest. 1993 Jul;92(1):359–371. doi: 10.1172/JCI116574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pociot F., Reimers J. I., Andersen H. U. Nicotinamide--biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992. Diabetologia. 1993 Jun;36(6):574–576. doi: 10.1007/BF02743277. [DOI] [PubMed] [Google Scholar]
  9. Stiller C. R., Dupré J., Gent M., Jenner M. R., Keown P. A., Laupacis A., Martell R., Rodger N. W., von Graffenried B., Wolfe B. M. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 1984 Mar 30;223(4643):1362–1367. doi: 10.1126/science.6367043. [DOI] [PubMed] [Google Scholar]
  10. Tarn A. C., Thomas J. M., Dean B. M., Ingram D., Schwarz G., Bottazzo G. F., Gale E. A. Predicting insulin-dependent diabetes. Lancet. 1988 Apr 16;1(8590):845–850. doi: 10.1016/s0140-6736(88)91601-7. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES